SeniorTrade Blog
The Business of Aging Well™



Inspiren Raises $100M Series B to Lead Senior Living's AI-Driven Future
Investment accelerates Inspiren's vision to help operators meet rising care demands with an integrated, AI-powered ecosystem Inspiren , a leader in AI-powered solutions redefining senior living, today announced it has raised $100 million in Series B funding. The financing was led by global software investor Insight Partners, with participation from Avenir, Primary Venture Partners, Scale Venture Partners, Story Ventures, Third Prime, and Studio VC. This brings Inspiren's to

Lilly Launches New "Brain Health Matters" Campaign
Launched during World Alzheimer's Month, the partnership with Julianne Moore empowers the public to prioritize brain health. Eli Lilly...


AlerisLife to Transition 116 Communities Managed by Five Star Senior Living to 7 Different Operators
AlerisLife is selling all assets, including its 17 owned communities, and expects to complete a full wind-down of its business and...

New Senior Housing Program Will Allow Older Adults to Live with Caregivers or Family Members
NYC Senior Affordable Rental Apartments (SARA) program to include two-bedroom units to accommodate multigenerational households. New York...



K4Connect and Zinnia Partner to Enhance Resident Engagement through Research-Driven Wellness Content
K4Connect partners with Zinnia to bring calming video content for residents with Alzheimer’s and related dementias, all in the K4TV and...



Argentum and A Place for Mom Release the State of Technology in Senior Living Report
76% of senior living leaders believe AI for predictive analytics, staffing efficiency, and resident engagement will have a positive or...


Integrated Healthcare Platform Centered Care Acquires Troupe Health
Acquisition Expands Access to Tech-Enabled Care Coordination in Seniors Housing , improving care delivery, operational efficiency, and...

FDA Clears First Blood Test for Diagnosing Alzheimer’s
On May 16, 2025, the U.S. Food and Drug Administration (FDA) granted clearance for the first blood test designed to aid in diagnosing...











